Post by Recipharm

𝗪𝗲 𝗮𝗿𝗲 𝗲𝘅𝗽𝗮𝗻𝗱𝗶𝗻𝗴 𝗼𝘂𝗿 𝗕𝗹𝗼𝘄-𝗙𝗶𝗹𝗹-𝗦𝗲𝗮𝗹 (𝗕𝗙𝗦) 𝗺𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴 𝗰𝗮𝗽𝗮𝗰𝗶𝘁𝘆 𝘄𝗶𝘁𝗵 𝗮 𝗻𝗲𝘄 𝘀𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗰 𝗶𝗻𝘃𝗲𝘀𝘁𝗺𝗲𝗻𝘁 𝗱𝗲𝘀𝗶𝗴𝗻𝗲𝗱 𝘁𝗼 𝘀𝘂𝗽𝗽𝗼𝗿𝘁 𝗴𝗿𝗼𝘄𝗶𝗻𝗴 𝗰𝘂𝘀𝘁𝗼𝗺𝗲𝗿 𝗱𝗲𝗺𝗮𝗻𝗱. With 50 years of BFS expertise, we provide integrated support across the product lifecycle, from early development and clinical supply through to commercial manufacturing for ophthalmic programmes and vaccine applications across biologics and small molecules. BFS technology plays an important role in modern sterile manufacturing by enabling highly automated aseptic processing, reducing complexity across the supply chain and supporting more efficient large-scale production. This latest investment further strengthens our position as a global partner for sterile manufacturing solutions.   Read more in the full press release: https://lnkd.in/ezAwdrhd #Recipharm #BFS #SterileManufacturing #CDMO #Ophthalmics #Vaccines #PharmaManufacturing